Physiological Role
Folate, or vitamin B9, is a water-soluble vitamin that the body cannot synthesize. It must be obtained through diet: green leafy vegetables, legumes, liver, and citrus fruits. Once absorbed, folate is converted into 5-methyltetrahydrofolate (5-MTHF), its biologically active form. This conversion involves several successive reactions, the last of which is carried out by the enzyme MTHFR (methylenetetrahydrofolate reductase), whose activity varies with genetic profile.
5-MTHF plays a key role in the methylation cycle. It provides a methyl group to homocysteine to reconvert it into methionine, an essential amino acid. This transfer is carried out by methionine synthase and requires vitamin B12 as a cofactor. Methionine is then transformed into S-adenosylmethionine (SAM), the body's primary methyl donor. SAM is involved in gene regulation, neurotransmitter synthesis, and DNA integrity maintenance.
Serum folate is a direct measurement of circulating vitamin B9, with no intermediate calculation. It reflects intake over recent days and the state of the current diet: after about three months of steady intake, its concentration stabilizes. Red blood cell folate, which some laboratories also offer, measures a different quantity, on a scale about thirty times higher. The two results are not comparable.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
Serum folate provides a direct reading of vitamin B9 status. Values within the optimal range indicate sufficient intake to support the methylation cycle and normal cell division.
Low values may reflect insufficient dietary intake, reduced intestinal absorption, or increased requirements linked to a genetic polymorphism. A sustainably low folate status is associated with elevated homocysteine, a marker of methylation cycle function that Singular measures concurrently.
Serum folate responds to recent intake: a meal, a supplement or a change in diet shifts it within hours. This is why the sample is taken in the morning, in a fasted state, and after non-prescribed supplements have been suspended. High values most often reflect a high intake, dietary or supplemental. Their interpretation depends on vitamin B12 status: an unfavourable association is observed only when vitamin B12 is low. Singular measures both markers in the same test. Regular monitoring helps distinguish a one-time variation from a lasting trend.
Serum folate is read in conjunction with vitamin B12 and homocysteine. These three markers, measured together, provide a map of the methylation cycle. Mean corpuscular volume (MCV) provides complementary information: an elevated MCV may signal increased folate or vitamin B12 requirements.
Influencing Factors
Diet. Green leafy vegetables (spinach, broccoli, asparagus), legumes, liver, and citrus fruits are the richest dietary sources of natural folates. Prolonged cooking significantly reduces folate content in food.
Meals and sampling time. Serum folate rises as soon as a meal ends and stays above its fasting value for the following twenty-four hours. A postprandial kinetics study measured almost 30% difference twelve hours after a standardized breakfast. It noted that 17% of participants would have been classified differently depending on sampling time. The Singular protocol therefore requires a morning sample, after twelve hours of fasting.
Genetics. The MTHFR C677T polymorphism occurs in homozygous form in 4 to 26% of Europeans depending on the region. Under laboratory conditions, it lowers by up to 70% the activity of the enzyme that produces the active form of folate. Serum folate in homozygous carriers is about 20 to 25% lower. Carriers have increased folate requirements.
Intestinal absorption. Dietary folates are absorbed primarily in the proximal jejunum (upper part of the small intestine). A compromised intestinal mucosa may reduce this absorption. Alcohol consumption also interferes with intestinal folate transport.
Alcohol. Regular alcohol consumption decreases intestinal folate absorption and accelerates urinary excretion. This effect is dose-dependent and represents one of the most common factors behind low folate status.
Medications. Certain medications can interfere with folate metabolism, notably methotrexate, some anticonvulsants, and oral contraceptives.
Age and increased requirements. Folate requirements increase during pregnancy and breastfeeding. With age, intestinal absorption may decrease. Older adults more frequently present low serum folate values.
Supplementation. 5-methyltetrahydrofolate (5-MTHF) is the form in which folate circulates in plasma, whichever form is ingested. A daily intake raises serum folate within a few weeks, after which its concentration stabilizes at around three months.
In the Singular Formula
Vitamin B9 is one of the markers most directly integrated into the Singular personalization engine. Serum folate serves as both a nutritional adjustment parameter and a reading point for the methylation cycle.
Below the optimal range, the formula supplies vitamin B9 as 5-MTHF (calcium L-5-methyltetrahydrofolate), at a level that follows where the result sits. Folate contributes to normal blood formation. In the first third of the optimal range, the formula keeps a maintenance dose. Beyond that, no rule adds vitamin B9 on folate status alone.
The formulation engine also accounts for homocysteine. Three conditions raise 5-MTHF to its reinforced dosage: elevated homocysteine, low vitamin B9, and a vitamin B12 that is not itself low. Folate contributes to normal homocysteine metabolism. Four conditions are met here. Vitamin B9 and vitamin B12 are optimal, homocysteine is elevated, and alkaline phosphatase is not very high. The formula then combines vitamin B9 and vitamin B12 (methylcobalamin) at their maintenance dose.
Vitamin B6 (P5P) completes this system: it is involved in the transsulfuration pathway, the other homocysteine recycling route. Its dosage is not adjusted according to serum folate.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Chen S, Honda T, Hata J, et al. | 2021 | Cohort Study | The Journal of Nutrition | View on PubMed |
High Serum Folate Concentrations Are Associated with Decreased Risk of Mortality among Japanese Adults Japanese cohort of 3,050 adults aged 40 and over, followed for 10.2 years, in a country where flour is not fortified with folic acid. All-cause mortality was lower in the highest serum folate tertile (HR 0.61) than in the lowest. Risk declined up to a plateau between 20 and 25 nmol/L, after which the curve flattened. | ||||
| Zhao Q, Lv X, Liu Q, et al. | 2024 | Cohort Study | Frontiers in Nutrition | View on PubMed |
Association between serum folate concentrations and all-cause mortality in U.S. adults: a cohort study based on National Health and Nutrition Examination Survey III 12,862 adults followed for 26.4 years, 5,299 deaths. Compared with the lowest serum folate quartile, the three upper quartiles showed lower all-cause mortality (0.84, then 0.78 and 0.78). Over this follow-up duration, no excess risk appeared at the highest concentrations. | ||||
| Xu J, Zhu X, Guan G, et al. | 2023 | Cohort Study | Hypertension Research | View on PubMed |
Non-linear associations of serum and red blood cell folate with risk of cardiovascular and all-cause mortality in hypertensive adults 13,986 hypertensive adults, with both folate measurements taken in the same people. The relationship with mortality is not linear: inflection points sit at 12.3 ng/mL for cardiovascular mortality and 20.5 ng/mL for all-cause mortality. The lowest red blood cell folate quartile, by contrast, was associated with neither outcome. | ||||
| Chen MY, Rose CE, Qi YP, et al. | 2019 | Randomised Controlled Trial | The American Journal of Clinical Nutrition | View on PubMed |
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation Randomized trial run by the CDC in 1,673 women. It measures the correspondence between plasma folate and red blood cell folate in the same people, and shows that the plasma concentration plateaus at three months while the red blood cell concentration has not plateaued by six months. The correspondence depends on vitamin B12 status. | ||||
| Liu M, Zhang Z, Zhou C, et al. | 2021 | Cohort Study | Clinical Nutrition | View on PubMed |
Relationship of several serum folate forms with the risk of mortality: A prospective cohort study 10,661 US adults, with folate forms measured by mass spectrometry. Mortality was higher at both ends of the distribution: lowest quartile (HR 1.66) and highest quartile (HR 1.61). Median follow-up was short, 2.99 years, which limits the scope of the result. | ||||
| Morris MS, Jacques PF, Rosenberg IH, Selhub J | 2007 | Cohort Study | The American Journal of Clinical Nutrition | View on PubMed |
Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification 1,459 US adults aged 60 and over. Serum folate above the 80th percentile was associated with less favourable haematological and cognitive outcomes only in subjects whose vitamin B12 was low. In those with normal vitamin B12, the association reversed. This is the result that justifies reading both markers together. | ||||
| Anfinsen ÅM, Johannesen CO, Myklebust VH, et al. | 2024 | Clinical Trial | The British Journal of Nutrition | View on PubMed |
Time-resolved concentrations of serum amino acids, one-carbon metabolites and B-vitamin biomarkers during the postprandial and fasting state: the Postprandial Metabolism in Healthy Young Adults (PoMet) Study 34 young adults, 13 samples over 24 hours after a standardized breakfast. Serum folate rose as soon as the meal ended and stayed above its fasting value throughout the 24 hours, with almost 30% difference at 12 hours. The authors note that 17% of participants would have been classified differently depending on sampling time. | ||||
| Wilcken B et al. | 2003 | Cohort Study | J Med Genet | View on PubMed |
Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide Cohort study of over 7,000 newborns from 16 world regions, documenting the prevalence of the MTHFR C677T polymorphism by geographical and ethnic origin. | ||||
| Fallah M, Karim Dehnavi M, Lotfi K, et al. | 2025 | Meta-analysis | Nutrition Reviews | View on PubMed |
Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies 25 cohorts, 423,304 participants, 36,558 deaths. Comparing highest with lowest, folate biomarkers were not significantly associated with all-cause mortality (HR 0.91; 0.77-1.06). The only significant signal concerned dietary intake (HR 0.87). | ||||
| Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M | 2017 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Homocysteine-lowering interventions for preventing cardiovascular events 15 randomized trials, 71,422 participants, up to 7.3 years of follow-up. Lowering homocysteine with B vitamins did not change all-cause mortality (RR 1.01; 0.96-1.06), with high-quality evidence and no heterogeneity between trials. | ||||